| Test Article | Matrix | Species | Anticoagulant | Assay Type | LLOQ-ULOQ |
|---|---|---|---|---|---|
| Total Glucagon-Like Peptide-1 (GLP-1) | Plasma | Human | EDTA | ECL | 2.44-2500 |
| Melatonin | Saliva | Human | none | ELISA | 0.6-25 |
| Tissue Plasminogen Activator (tPA or PLAT) | Plasma | Rabbit | EDTA | ELISA | 15.6-500 |
| Adiponectin | Serum | Human | None | ELISA | 5-300 |
| Total Glucagon-Like Peptide-1 (GLP-1) | Plasma | Human | EDTA | ELISA | 2-100 |
| Serum Amyloid-A | Serum | Porcine | None | ELISA | 125-2000 |
| C-Reactive Protein | Serum | Porcine | None | ELISA | 3-100 |
| Haptoglobin | Serum | Porcine | None | ELISA | 6.25-400 |
| Active Glucagon-Like Peptide-1 (GLP-1) | Plasma | Human | EDTA | ELISA-ECL | 0.002-2.5 |
| Dipeptidylpeptidase IV (DPP IV) | Plasma | Human | Citrate | Fluorimetric Enzyme | Enzyme |
| 3,4-Dihydroxyphenylglycol | Cerebrospinal Fluid | Human | None | LC-EC | 0.1-10 |
| 3,4-Dihydroxyphenylacetic Acid | Cerebrospinal Fluid | Human | None | LC-EC | 0.1-40 |
| Epinephrine | Plasma | Human | EDTA | LC-EC | 100-2000 |
| 3-O-Methyldopa | Plasma | Human | EDTA | LC-EC | 5-250 |
| 3,4-Dihydroxyphenylacetic Acid | Plasma | Human | EDTA | LC-EC | |
| Carbidopa | Plasma | Human | EDTA | LC-EC | 10-2000 |
| Levodopa | Plasma | Human | EDTA | LC-EC | 10-2000 |
| Norepinephrine | Plasma | Human | EDTA | LC-EC | 0.25-2.25 |
| Levodopa | Cerebrospinal Fluid | Human | None | LC-EC | 0.1-10 |
| Epinephrine | Cerebrospinal Fluid | Human | None | LC-EC | 0.1-10 |
| Norepinephrine | Plasma | Human | EDTA | LC-EC | 150-3000 |
| Levodopa | Plasma | Human | EDTA | LC-EC | 10-2000 |
| Azithromycin | Plasma | Human | Heparin | LC-EC | 12.5-1000 |
| Azithromycin | Serum | Human | None | LC-EC | 10.4-1000 |
| Homovanillic Acid | Plasma | Human | EDTA | LC-EC | 5-250 |
| 3,4-Dihydroxyphenylglycol | Plasma | Human | EDTA | LC-EC | 0.5-4.5 |
| Carbidopa | Plasma | Human | EDTA | LC-EC | 10-2000 |
| Nitrite | Plasma | Rabbit | None | LC-FL | 250-8000 |
| Nitrite | Plasma | Rat | Heparin | LC-FL | 250-8000 |
| Nitrite | Plasma | Dog | Heparin | LC-FL | 200-8000 |
| Nitrite | Plasma | Human | Heparin | LC-FL | 15-1200 |
| Nitrite | Plasma | Human | Heparin | LC-FL | 150-8000 |
| Paclitaxel | Seminal Fluid | Human | None | LC-MS/MS | 0.1-100 |
| Paclitaxel | Urine | Human | None | LC-MS/MS | 0.1-100 |
| Paclitaxel | Plasma | Dog | Heparin | LC-MS/MS | 0.1-100 |
| Paclitaxel | Urethral and Prostate Tissues | Dog | None | LC-MS/MS | 0.3-300 |
| Paclitaxel | Urethral and Prostate Tissues | Dog | None | LC-MS/MS | 0.3-400 |
| Oxymorphone and 6β-Hydroxyoxymorphone Metabolite | Plasma | Human | EDTA | LC-MS/MS | 20-2000 |
| Cyanide | Whole Blood (Lysed) | Human | EDTA | LC-MS/MS | 25-2500 |
| Abiraterone | Plasma | Human | EDTA/Heparin | LC-MS/MS | 0.5-420 |
| Lenalidomide | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Rapamycin | Whole Blood (Lysed) | Dog | EDTA | LC-MS/MS | 0.1-100 |
| Rapamycin | Arterial Tissue | Porcine | None | LC-MS/MS | 50-5000 |
| Octenidine | Plasma | Human | EDTA | LC-MS/MS | 1-10 |
| Rapamycin | Arterial Tissue | Porcine | None | LC-MS/MS | 0.2-100 |
| Chlorhexidine | Plasma | Rabbit | EDTA | LC-MS/MS | 0.5-50 |
| Bupivacaine | Plasma | Human | EDTA | LC-MS/MS | 0.5-500 |
| Metformin | Plasma | Human | EDTA | LC-MS/MS | 20-5000 |
| Dechloroethylcyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 0.1-10 |
| Eicosapentaenoic acid | Plasma | Human | None | LC-MS/MS | 400-45000 |
| 4-Ketocyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 0.1-10 |
| Methotrexate and 7-Hydroxymethotrexate Metabolite | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| 6β-Hydroxycortisol | Urine | Human | None | LC-MS/MS | 1-1000 |
| Methotrexate and 7-Hydroxymethotrexate Metabolite | Urine | Human | None | LC-MS/MS | 20-10000 |
| Cortisol | Urine | Human | None | LC-MS/MS | 5-1000 |
| Gemcitabine and 2’,2’-Difluoro-2’-Deoxyuridine (dFdU) Metabolite | Plasma (THU-treated) | Human | Heparin | LC-MS/MS | 50-50000 |
| Levonorgestrel | Plasma | Human | EDTA | LC-MS/MS | 100-10000 |
| Paclitaxel | Plasma | Human | EDTA | LC-MS/MS | 5-5000 |
| Quetiapine Sulfoxide | Plasma | Human | EDTA | LC-MS/MS | 0.5-500 |
| Norquetiapine | Plasma | Human | EDTA | LC-MS/MS | 0.5-500 |
| Rapamycin | Whole Blood (Lysed) | Cat | EDTA | LC-MS/MS | 0.1-100 |
| Pioglitazone | Plasma | Human | EDTA | LC-MS/MS | 25-2500 |
| Rapamycin | Whole Blood (Lysed) | Monkey | EDTA | LC-MS/MS | 0.1-100 |
| Norepinephrine | Cerebrospinal Fluid | Human | None | LC-MS/MS | 0.1-10 |
| Pioglitazone-MIII and -MIV | Plasma | Human | EDTA | LC-MS/MS | 2.5-2500 |
| Rapamycin | Whole Blood (Lysed) | Monkey | EDTA | LC-MS/MS | 1000-40000 |
| Pioglitazone-MIII and -MIV | Urine | Human | None | LC-MS/MS | 2.5-2500 |
| Bendamustine and M3 and M4 Metabolites | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| Paclitaxel | Plasma | Rat | Heparin | LC-MS/MS | 0.1-100 |
| Docetaxel | Plasma | Human | Heparin | LC-MS/MS | 10 |
| Noroxycodone | Plasma | Human | EDTA | LC-MS/MS | 1-100 |
| Oxycodone | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Oxymorphone | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Rifampin | Plasma | Rabbit | Heparin | LC-MS/MS | 2.5-100 |
| Genistein | Serum | Human | None | LC-MS/MS | 1-1000 |
| Oseltamivir Carboxylate | Plasma | Heparin | LC-MS/MS | 10-10000 | |
| 3-Methoxytyramine | Cerebrospinal Fluid | Human | None | LC-MS/MS | 0.05-5 |
| Doxorubicin | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Homovanillic Acid | Cerebrospinal Fluid | Human | None | LC-MS/MS | 5-500 |
| Eletriptan | Plasma | Human | Heparin | LC-MS/MS | 0.5-250 |
| Ribavirin | Plasma | Rat | EDTA | LC-MS/MS | 10-5000 |
| Tacrolimus | Whole Blood | Human | EDTA | LC-MS/MS | 0.1-100 |
| Fenofibric Acid | Plasma | Mouse | EDTA | LC-MS/MS | 1-1000 |
| Acetylsalicylic Acid | Plasma | Dog | EDTA | LC-MS/MS | 5-500 |
| Salicylic Acid | Plasma | Dog | EDTA | LC-MS/MS | 50-5000 |
| Ketoconazole and Fluconazole | Plasma | Human | EDTA | LC-MS/MS | 10-10000 |
| 6-Sulfatoxymelatonin Sulfate | Urine | Human | None | LC-MS/MS | 0.2-200 |
| Quetiapine | Plasma | Human | EDTA | LC-MS/MS | 0.5-500 |
| Bortezomib | Plasma | Human | Heparin | LC-MS/MS | 1-250 |
| Tesaglitazar | Plasma | Mouse | EDTA | LC-MS/MS | 1-1000 |
| Artesunate | Plasma | Human | Heparin | LC-MS/MS | 10-2000 |
| Morphine-6β-D-Glucuronide | Plasma | Human | EDTA | LC-MS/MS | 0.1-50 |
| Acetaminophen | Plasma | Human | EDTA | LC-MS/MS | 4-2000 |
| Hydroxymidazolam | Plasma | Human | EDTA | LC-MS/MS | 0.3-300 |
| Paclitaxel | Serum | Mouse | None | LC-MS/MS | 0.3-300 |
| Glycinexylidide | Plasma | Human | EDTA | LC-MS/MS | 0.5-50 |
| Morphine | Plasma | Human | EDTA | LC-MS/MS | 0.02-10 |
| Monoethylglycinexlidide | Plasma | Human | EDTA | LC-MS/MS | 0.5-50 |
| Atropine | Plasma | Human | EDTA | LC-MS/MS | 0.05-250 |
| Dopamine | Plasma | Human | EDTA | LC-MS/MS | 2-1000 |
| Chlorpheniramine | Plasma | Human | EDTA | LC-MS/MS | 0.2-50 |
| Pseudoephedrine | Plasma | Human | EDTA | LC-MS/MS | 5-2500 |
| Gemfibrozil | Plasma | Human | EDTA | LC-MS/MS | 50-50000 |
| Hydrochlorothiazide | Plasma | Human | EDTA | LC-MS/MS | 1-500 |
| Hydrochlorothiazide | Urine | Human | None | LC-MS/MS | 100-10000 |
| Simvastatin and Simvastatin Hydroxy Acid Metabolite | Plasma | v | EDTA | LC-MS/MS | 0.05-100 |
| Fluconazole | Plasma | Human | EDTA | LC-MS/MS | 10-10000 |
| Lisinopril | Plasma | Human | Heparin | LC-MS/MS | 1-500 |
| Ivermectin H2B1b | Plasma | Human | Heparin | LC-MS/MS | 2.5-20 |
| Dexamethasone | Endocardial and Myocardial Tissue | Dog | None | LC-MS/MS | 1-1000 |
| Dexamethasone Phosphate | Plasma | Rabbit | EDTA | LC-MS/MS | 0.2-200 |
| Pseudoephedrine | Plasma | Human | EDTA | LC-MS/MS | 50-1000 |
| Hydrocodone | Plasma | Human | EDTA | LC-MS/MS | 0.2-100 |
| 4-Hydroxycyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 5-500 |
| Methylphenidate | Plasma | Rat | EDTA | LC-MS/MS | 5-5000 |
| Paclitaxel | Arterial Tissue | Porcine | None | LC-MS/MS | 0.5-500 |
| Paraxanthine (1,7-Dimethylxanthine) | Plasma | Human | EDTA | LC-MS/MS | 25-20000 |
| Iopromide | Plasma & Tissue | Porcine | EDTA | LC-MS/MS | 1-1000, 100-30000 |
| Pioglitazone | Urine | Human | None | LC-MS/MS | 1-1000 |
| Dihydroartemisinin | Plasma | Human | Heparin | LC-MS/MS | 10-2000 |
| Paclitaxel | Serum | Dog | None | LC-MS/MS | 0.03-30 |
| Dehydroaripiprazole | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Salicylic Acid | Plasma | Dog | Sodium Fluoride and Potassium Oxalate | LC-MS/MS | 500-150000 |
| Rapamycin | Arterial Tissue | Porcine | None | LC-MS/MS | 0.1-50 |
| Risperidone and 9-Hydroxyrisperidone Metabolite | Plasma | Human | Heparin | LC-MS/MS | 0.1-100 |
| Paclitaxel | Plasma | Human | Heparin | LC-MS/MS | 20-5000 |
| Sitagliptin | Urine | Human | None | LC-MS/MS | 1-1000 |
| Olanzapine and N-Desmethyl Olanzapine Metabolite | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Efavirenz | Plasma | Human | Heparin | LC-MS/MS | 200-10000 |
| Oxymorphone | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Metoprolol and Alpha-Hydroxy Metoprolol Metabolite | Plasma | Human | Heparin | LC-MS/MS | 5-500 |
| Noroxycodone | Plasma | Plasma | EDTA | LC-MS/MS | 0.1-100 |
| Oseltamivir | Plasma | Human | Heparin | LC-MS/MS | 1-250 |
| Rapamycin | Myocardial Tissue | Porcine | None | LC-MS/MS | 0.5-500 |
| Rapamycin | Arterial Tissue | Porcine | None | LC-MS/MS | 0.5-500 |
| Rapamycin | Whole Blood | Porcine | EDTA | LC-MS/MS | 0.1-100 |
| Rapamycin | Liver Tissue | Porcine | None | LC-MS/MS | 0.5-500 |
| Rapamycin | Kidney Tissue | Porcine | None | LC-MS/MS | 0.5-500 |
| Rapamycin | Lung Tissue | Porcine | None | LC-MS/MS | 0.5-500 |
| Rapamycin | Tissues | Porcine | None | LC-MS/MS | 0.5-500 |
| Pioglitazone | Serum | Human | None | LC-MS/MS | 25-2500 |
| Diltiazem | Plasma | Human | Heparin | LC-MS/MS | 1-500 |
| Levofloxacin | Plasma | Human | EDTA | LC-MS/MS | 10-10000 |
| Aripiprazole | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Lorazepam | Plasma | Human | EDTA | LC-MS/MS | 0.3-100 |
| Tiagabine | Plasma | Human | EDTA | LC-MS/MS | 0.5-500 |
| Naproxen | Plasma | Human | Heparin | LC-MS/MS | 100-100000 |
| Desipramine | Plasma | Human | EDTA | LC-MS/MS | 0.2-100 |
| Daunorubicin | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Ziprasidone | Plasma | Human | EDTA | LC-MS/MS | 0.2-200 |
| Midazolam | Plasma | Human | EDTA | LC-MS/MS | 0.3-300 |
| Naproxen (on-line extraction) | Plasma | Human | Heparin | LC-MS/MS | 100-100000 |
| Diltiazem | Plasma | Dog | EDTA | LC-MS/MS | 0.05-50 |
| Acetylsalicylic Acid | Plasma | Dog | Sodium Fluoride and Potassium Oxalate | LC-MS/MS | 50-15000 |
| Melatonin | Plasma | Human | EDTA | LC-MS/MS | 1-100 |
| Metformin | Serum | Human | None | LC-MS/MS | 10-3500 |
| Glimepiride | Serum | Human | N/A | LC-MS/MS | 1-500 |
| Simvastatin & Simvastatin β-hydroxy Acid Metabolite | Plasma | Human | EDTA | LC-MS/MS | 0.05-10 |
| Tenofovir | Plasma | Human | EDTA | LC-MS/MS | 5-500 |
| Testosterone | Plasma and Serum | Porcine | EDTA | LC-MS/MS | 0.1-20 |
| Dexamethasone | Plasma | Dog | EDTA | LC-MS/MS | 0.001-100 |
| Capecitabine and Metabolites (Prodrug for 5-Fluorouracil) | Plasma | Human | Heparin | LC-MS/MS | 75-10000 |
| Hydroxymidazolam | Plasma | Human | EDTA | LC-MS/MS | 0.3-300 |
| Renzapride | Plasma | Human | EDTA/Heparin | LC-MS/MS | 0.1-10 |
| Caffeine | Plasma | Human | EDTA | LC-MS/MS | 25-20000 |
| Mycophenolic Acid | Plasma | Human | Heparin | LC-MS/MS | 50-10000 |
| Docetaxel | Plasma Ultrafiltrate | Human | Heparin | LC-MS/MS | 2-100 |
| Muraglitazar | Plasma | Mouse | EDTA | LC-MS/MS | 1-1000 |
| Docetaxel | Plasma | Human | EDTA/Heparin | LC-MS/MS | 1-1000 |
| Temozolomide | Plasma | Rat | Heparin | LC-MS/MS | 10-2000 |
| Erythromycin | Plasma | Human | Heparin | LC-MS/MS | 10-10000 |
| Baclofen | Plasma | Human | Heparin | LC-MS/MS | 20-1000 |
| Efavirenz | Plasma | Human | EDTA/Heparin | LC-MS/MS | 200-10000 |
| Phentermine | Plasma | Human | Heparin | LC-MS/MS | 2.5-500 |
| Spironolactone | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| Amiodarone and Desethylamiodarone | Plasma | Human | EDTA | LC-MS/MS | 5-3000 |
| Delta-9-Tetrahydrocannabinol (THC) and 11-Hydroxy Metabolite | Plasma | Human | Heparin | LC-MS/MS | 0.05-50 |
| Hydrocodone | Plasma | Human | EDTA | LC-MS/MS | 0.2-100 |
| Naloxone | Plasma | Human | EDTA | LC-MS/MS | 1-200 |
| Omeprazole | Plasma | Human | Heparin | LC-MS/MS | 10-1000 |
| Fentanyl | Serum | Human | None | LC-MS/MS | 0.05-10 |
| Rifabutin | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| 25-O-Desacetylrifabutin | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| Carbamazepine and Carbamazepine-10,11-Epoxide | Plasma | Human | EDTA | LC-MS/MS | 5-5000 |
| Docetaxel | Plasma Ultrafiltrate | Human | Heparin | LC-MS/MS | 2-100 |
| Emtricitabine | Plasma | Human | EDTA | LC-MS/MS | 5-500 |
| Raltegravir | Plasma | Human | EDTA/Heparin | LC-MS/MS | 2-1000 |
| Ivermectin H2B1a | Plasma | Human | Heparin | LC-MS/MS | 2.5-1000 |
| Cortisol | Urine | Human | None | LC-MS/MS | 0.5-500 |
| Cortisol | Urine | None | LC-MS/MS | 1-500 | |
| Docetaxel | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| Melatonin | Saliva | Human | None | LC-MS/MS | 0.001-0.1 |
| Pioglitazone, Pioglitazone MIII, Pioglitazone MIV | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Pioglitazone-MIII and -MIV | Plasma | Human | EDTA | LC-MS/MS | 25-2500 |
| Rapamycin | Whole Blood (Lysed) | Porcine | EDTA | LC-MS/MS | 0.1-100 |
| Everolimus | Whole Blood | Human | EDTA | LC-MS/MS | 0.25-250 |
| Paclitaxel and 6α-Hydroxy Paclitaxel Metabolite | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Cyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 250-25000 |
| Fentanyl | Serum | Human | None | LC-MS/MS | 0.05-10 |
| Lidocaine | Plasma | Human | EDTA | LC-MS/MS | 0.5-50 |
| Ondansetron | Urine | Human | None | LC-MS/MS | 0.2-2000 |
| Ondansetron | Plasma | Human | EDTA | LC-MS/MS | 0.2-2000 |
| Ondansetron | Dried Whole Blood | Human | None | LC-MS/MS | 0.2-100 |
| Hydrochlorothiazide | Dried Whole Blood | Human | None | LC-MS/MS | 1-500 |
| Nicotine | Plasma | Human | EDTA | LC-MS/MS | 2-200 |
| Clonidine | Plasma | Rat | EDTA | LC-MS/MS | 5-5000 |
| Octenidine | Plasma | Mini Pig | EDTA | LC-MS/MS | 1-10 |
| Benzophenone | Plasma | Human | EDTA | LC-MS/MS | 5-5000 |
| 6β-Hydroxycortisol | Urine | Human | None | LC-MS/MS | 10-2000 |
| Guanethidine | Plasma | Porcine | EDTA | LC-MS/MS | 1-1000 |
| Tamoxifen | Plasma | Human | Heparin | LC-MS/MS | 0.5-500 |
| Diltiazem | Plasma | Rat | Heperain | LC-MS/MS | 1-500 |
| Levodopa | Plasma | Human | EDTA | LC-MS/MS | 2-1000 |
| Paclitaxel | Seminal Fluid | Human | None | LC-MS/MS | 0.1-100 |
| Donepezil | Plasma | Porcine | EDTA | LC-MS/MS | 0.03-10 |
| Scopolamine | Plasma | Human | EDTA | LC-MS/MS | 0.01-20 |
| Dexamethasone | Plasma | Porcine | EDTA | LC-MS/MS | 0.1-100 |
| Oxycodone | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Ketoprofen | Plasma | Rat | EDTA | LC-MS/MS | 1-1000 |
| Ketoprofen | Plasma | Porcine | EDTA | LC-MS/MS | 1-1000 |
| Clonazepam | Plasma | Human | EDTA | LC-MS/MS | 0.100-100 |
| Gabapentin | Plasma | Human | Heparin | LC-MS/MS | 2-10000 |
| Sunitinib and N-desethyl Sunitinib | Plasma | v | EDTA | LC-MS/MS | 1-100 |
| Donepezil | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Docetaxel | Plasma | Mouse | Heparin | LC-MS/MS | 50-5000 |
| Montelukast | Plasma | Human | Heparin | LC-MS/MS | 1.25-1250 |
| Chlorpheniramine | Plasma | Human | EDTA | LC-MS/MS | 0.2-100 |
| Docetaxel | Plasma | Dog | Heparin | LC-MS/MS | 10-2500 |
| Ribavirin | Plasma | Rat | EDTA | LC-MS/MS | 10-5000 |
| Rapamycin | Whole Blood | Human | EDTA | LC-MS/MS | 0.1-100 |
| Warfarin (R and S enantiomers separated) | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| Rimonabant | Plasma | Human | EDTA | LC-MS/MS | 0.1-100 |
| Ethinyl Estradiol | Plasma | Human | EDTA | LC-MS/MS | 5-500 |
| Paroxetine | Plasma | Human | EDTA | LC-MS/MS | 0.1-60 |
| Ciprofloxacin | Plasma | Human | EDTA | LC-MS/MS | 100-10000 |
| Nordiazepam | Plasma | Human | EDTA | LC-MS/MS | 0.3-300 |
| Sildenafil and N-Desmethyl Sildenafil Metabolite | Plasma | Human | Heparin | LC-MS/MS | 1-500 |
| Paclitaxel | Plasma | Dog | Heparin | LC-MS/MS | 0.1-100 |
| Paclitaxel | Plasma Ultrafiltrate | Dog | EDTA | LC-MS/MS | 0.3-1000 |
| 5-Fluorouracil | Plasma | Human | EDTA/Heparin | LC-MS/MS | 10-10000 |
| Paclitaxel | Serum | Porcine | None | LC-MS/MS | 0.03-100 |
| Morphine and Metabolites | Plasma | Human or Dog | EDTA | LC-MS/MS | 1-500 |
| Granisetron | Plasma | Human and Dog | EDTA | LC-MS/MS | 1-1000 |
| Ondansetron | Plasma | Human or Dog | EDTA | LC-MS/MS | 1-1000 |
| Paclitaxel | Tissues | Porcine | None | LC-MS/MS | 0.3-500 |
| Paclitaxel | Plasma | Rabbit | EDTA/Heparin | LC-MS/MS | 0.03-30 |
| Paclitaxel | Serum | Rabbit | None | LC-MS/MS | 0.03-30 |
| Rizatriptan | Plasma | Human | Heparin | LC-MS/MS | 0.3-100 |
| Gemcitabine | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Sumatriptan | Plasma | Human | Heparin | LC-MS/MS | 0.5-500 |
| Tacrolimus | Whole Blood | Human | EDTA | LC-MS/MS | 0.1-100 |
| Docetaxel | Plasma | Human | Heparin | LC-MS/MS | 10-2500 |
| Midazolam | Plasma | Human | EDTA | LC-MS/MS | 0.3-300 |
| Alprazolam and Hydroxyalprazolam Metabolites | Plasma | Human | EDTA | LC-MS/MS | 0.3-1000 |
| Darunavir | Plasma | Human | EDTA | LC-MS/MS | 25-12500 |
| Ritonavir | Plasma | Human | EDTA | LC-MS/MS | 25-12500 |
| Paclitaxel | Serum | Porcine | None | LC-MS/MS | 0.03-30 |
| Paclitaxel | Whole Blood | Dog | Heparin | LC-MS/MS | 1-1000 |
| Paclitaxel | Whole Blood | Porcine | None | LC-MS/MS | 0.03-30 |
| Paclitaxel | Urine | Porcine | None | LC-MS/MS | 0.03-30 |
| Paclitaxel | Plasma | Porcine | EDTA/Heparin | LC-MS/MS | 0.03-30 |
| Everolimus | Whole Blood | Porcine | EDTA | LC-MS/MS | 0.1-100 |
| Everolimus | Tissues | Porcine | None | LC-MS/MS | 0.5-500 |
| Cyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 1-100 |
| Paclitaxel | Whole Blood | Human | None | LC-MS/MS | 1-1000 |
| Paclitaxel | Plasma or Plasma Ultrafiltrate | Human | EDTA/Heparin | LC-MS/MS | 0.1-1000 |
| Paclitaxel, 3-OH-Paclitaxel, & 6-OH-Paclitaxel | Dog & Rat Plasma | Heparin | LC-MS/MS | 0.100 | |
| Propofol | Human Plasma | EDTA | LC-UV | 100-15000 | |
| Theophylline | Plasma | Human | Heparin | LC-UV | 300-20000 |
| Acetylsalicylic Acid | Plasma | Human | EDTA | LC-UV | 100 |
| Acetaminophen | Plasma | Human | EDTA | MS | 4-2000 |
| Total Protein Content | White Blood Cell Lysate | Human | None | Spectrometer | 150-2000 |
| Total Protein Content | White Blood Cell Lysate | Human | None | Spectrometer | 25-2000 |